Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5511433 | The International Journal of Biochemistry & Cell Biology | 2017 | 24 Pages |
Abstract
The expression of mitochondrially-encoded genes requires the efficient processing of long precursor RNAs at the 5â² and 3â² ends of tRNAs, a process which, when disrupted, results in disease. Two such mutations reside within mt-tRNALeu(UUR); a m.3243AÂ >Â G transition, which is the most common cause of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes), and m.3302AÂ >Â G which often causes mitochondrial myopathy (MM). We used parallel analysis of RNA ends (PARE) that captures the 5â² terminal end of 5â²-monophosphorylated mitochondrial RNAs to compare the effects of the m.3243AÂ >Â G and m.3302AÂ >Â G mutations on mitochondrial tRNA processing and downstream RNA metabolism. We confirmed previously identified RNA processing defects, identified common internal cleavage sites and new sites unique to the m.3243AÂ >Â G mutants that do not correspond to transcript ends. These sites occur in regions of predicted RNA secondary structure, or are in close proximity to such regions, and may identify regions of importance to the processing of mtRNAs.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Stefan J. Siira, Anne-Marie J. Shearwood, Cameron P. Bracken, Oliver Rackham, Aleksandra Filipovska,